Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Equity: 2011-2025

Historic Return on Equity for Aytu Biopharma (AYTU) over the last 12 years, with Sep 2025 value amounting to 0.10%.

  • Aytu Biopharma's Return on Equity rose 18.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 18.00%. This contributed to the annual value of 0.03% for FY2025, which is 13.00% up from last year.
  • Per Aytu Biopharma's latest filing, its Return on Equity stood at 0.10% for Q3 2025, which was up 354.42% from 0.02% recorded in Q2 2025.
  • Aytu Biopharma's 5-year Return on Equity high stood at 0.10% for Q3 2025, and its period low was -2.06% during Q2 2022.
  • Moreover, its 3-year median value for Return on Equity was -0.11% (2024), whereas its average is -0.20%.
  • As far as peak fluctuations go, Aytu Biopharma's Return on Equity plummeted by 165bps in 2022, and later soared by 164bps in 2023.
  • Over the past 5 years, Aytu Biopharma's Return on Equity (Quarterly) stood at -0.77% in 2021, then tumbled by 86bps to -1.63% in 2022, then surged by 128bps to -0.35% in 2023, then climbed by 30bps to -0.04% in 2024, then rose by 18bps to 0.10% in 2025.
  • Its Return on Equity was 0.10% in Q3 2025, compared to 0.02% in Q2 2025 and -0.02% in Q1 2025.